Research-linked incentive scheme in works for pharmaceutical industry

15% turnover investment in research could make companies eligible for the scheme

The Centre may announce a Research-linked incentive (RLI) scheme for the Indian pharmaceutical industry to raise contribution to research and development and move up the value chain of innovation, sources close to the development said.

At least three people close to the matter said that such a scheme is indeed in the works, and the internal target is to raise contribution to R&D by pharma companies to 15 per cent of the turnover.

“The industry is in active discussion with the government and such a plan is in the works. The details of the RLI scheme is yet to be firmed up,